Proclaiming Teladoc Health (NYSE: TDOC) the Amazon of online health might seem strange at first. After all, Amazon launched Amazon Care in 2019 to offer health services for employees. The company has also purchased an online pharmacy.

The coronavirus pandemic accelerated a wellness renaissance among consumers as shelter in place orders took effect, based on some of the sales trends seen by companies including Ro.

Amazon.com (NASDAQ: AMZN), Netflix (NASDAQ: NFLX), and Teladoc Health (NYSE: TDOC) are three of these coronavirus stocks. It holds an additional edge because of its Amazon Web Services (AWS). Like most stocks, Amazon shares were initially sold off in mid-February.

Teladoc Health (NYSE: TDOC) stands to reap tens of millions of dollars more than it initially planned from an upcoming convertible senior notes issue. It also set the annual interest rate of the notes, which will be 1.25%. As Teladoc stated when it initially announced the issue last week, the notes from the upcoming issue will mature on June 1, 2027 if not converted, redeemed, or purchased.

Shares of the telehealth provider continued to fall as the market rotated out of high-growth stocks.

Many active investors buy stocks on the hope of scoring outsize returns by purchasing the next Apple or Tesla. They also might remember eras such as the dot-com bubble or the housing boom and assume that investing is a path to easy money.

Aside from our house, all the money my wife and I have saved over the last 30-plus years is invested in stocks. At 53 years young, we hold a concentrated investment portfolio that will fund our eventual retirement.

PURCHASE, NY, May 14, 2020 -- Teladoc Health, Inc. (NYSE:TDOC) (“Teladoc Health”) today announced the pricing of its offering of $850 million aggregate principal amount of.

With One Medical on such a tear as of late, let's take a look at what's driving the stock's recent surge and whether it has enough gas to reach $50. It wouldn't be impossible to see One Medical to rise to $50 based on the results it's shown investors thus far, but it's not a price point that appears to be sustainable just yet given the risks involved.

Now investors should look ahead to the post-vaccine world: Sell stocks that are hot today but will experience deteriorating earnings momentum after a vaccine comes out and buy quality stocks with good balance sheets that will experience positive earnings momentum in that new era. This chart compares the Dow Jones Industrial Average ETF (DIA) to seven stocks that I am using to illustrate shifts in money flows. • Zoom Video (ZM) has been one of the biggest beneficiaries of coronavirus.

Several top health care stocks are in buy zones or setting up, including Teladoc and Neurocrine Biosciences. They are all worth adding to your watchlist.

In this episode of Market Foolery, Chris Hill and Motley Fool analyst Jason Moser discuss the latest headlines from Wall Street. To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. To get started investing, check out our quick-start guide to investing in stocks.

The online furniture seller’s stock has soared ninefold during the lockdown. It could come under heavy pressure and traditional furniture stores get back to business.

The coronavirus pandemic has helped digital health surge like never before. With virtual visits increasing on a daily basis, we have five stocks that are set to gain.

Shares of Teladoc Health Inc. slumped 5.6% in morning trading Thursday, after the telehealth services company announced plans for an offering of $800 million in convertible senior unsecured notes due 2027. The company said it plans to use part of the proceeds to enter into negotiated agreements for certain holders of its 3.00% convertible senior note due 2022 to exchange those notes for a combination of cash and common stock. The offering is being made to qualified institutional buyers. Teladoc's stock has more than doubled (up 112%) year to date as shelter-at-home orders amid the COVID-19 pandemic has led to increased use of telemedicine services. In comparison, the SPDR Health Care Select Sector ETF has slipped 3.9% this year and the S&P 500 has lost 13.9%.

In a business maneuver that is becoming extremely common during these chaotic economic times, Teladoc Health (NYSE: TDOC) is aiming to raise some capital through an issue of convertible securities. Teladoc will hold the right to redeem them for cash starting June 5, 2024, under certain circumstances. Teladoc will use the proceeds partially to retire an issue of 3% convertible senior notes that matures in 2022.

Teladoc and these two e-commerce leaders are well-positioned to turn in serious returns during the years to come.

Is (TDOC) Outperforming Other Medical Stocks This Year?

Telehealth companies enabling individuals to see physicians without stepping foot into a physical doctor’s office are having their moment, as the coronavirus pandemic confines individuals and would-be patients across the country largely to their homes.

The health care industry has been rallying so far this year on constant testing and COVID-19 vaccine trials.